WO2002055687A2 - Souris transgeniques presentant des disruptions geniques cibles - Google Patents

Souris transgeniques presentant des disruptions geniques cibles Download PDF

Info

Publication number
WO2002055687A2
WO2002055687A2 PCT/US2001/048262 US0148262W WO02055687A2 WO 2002055687 A2 WO2002055687 A2 WO 2002055687A2 US 0148262 W US0148262 W US 0148262W WO 02055687 A2 WO02055687 A2 WO 02055687A2
Authority
WO
WIPO (PCT)
Prior art keywords
target gene
cell
gene
agent
disruption
Prior art date
Application number
PCT/US2001/048262
Other languages
English (en)
Other versions
WO2002055687A3 (fr
Inventor
Keith D Allen
Original Assignee
Deltagen Inc
Keith D Allen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deltagen Inc, Keith D Allen filed Critical Deltagen Inc
Publication of WO2002055687A2 publication Critical patent/WO2002055687A2/fr
Publication of WO2002055687A3 publication Critical patent/WO2002055687A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knock-out vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/20—Animal model comprising regulated expression system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0393—Animal model comprising a reporter system for screening tests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des animaux transgéniques, de même que des compositions et procédés relatifs à la caractérisation de la fonction génique. L'invention concerne notamment des souris transgéniques comprenant des mutations dans un gène cible. De telles souris transgéniques sont utiles en tant que modèles pour des maladies et pour l'identification d'agents modulant l'expression et la fonction géniques, et en tant que traitements potentiels de diverses pathologies et maladies.
PCT/US2001/048262 2000-12-13 2001-12-13 Souris transgeniques presentant des disruptions geniques cibles WO2002055687A2 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US25620600P 2000-12-13 2000-12-13
US32689201P 2001-10-02 2001-10-02
US60/326,892 2001-10-02
US1554901A 2001-12-11 2001-12-11
US10/015,549 2001-12-11
US60/256,206 2002-02-12

Publications (2)

Publication Number Publication Date
WO2002055687A2 true WO2002055687A2 (fr) 2002-07-18
WO2002055687A3 WO2002055687A3 (fr) 2003-05-22

Family

ID=27360372

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/048262 WO2002055687A2 (fr) 2000-12-13 2001-12-13 Souris transgeniques presentant des disruptions geniques cibles

Country Status (1)

Country Link
WO (1) WO2002055687A2 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA989497B (en) * 1997-10-20 2000-04-19 Roche Diagnostics Gmbh Positive-negative selection in homologous recombination.

Also Published As

Publication number Publication date
WO2002055687A3 (fr) 2003-05-22

Similar Documents

Publication Publication Date Title
US20030106083A1 (en) Transgenic mice containing RPTPB tyrosine phosphatase gene disruptions
US20020133841A1 (en) Transgenic mice containing huntingtin interacting protein gene disruptions
US20020169307A1 (en) Transgenic mice containing LPR5 gene disruptions
WO2002006445A9 (fr) Souris transgenique contenant des disruptions geniques ciblees
US20030079243A1 (en) Transgenic mice containing TRP6 calcium ion channel gene disruptions
US20020108138A1 (en) Transgenic mice containing RORgamma gene disruptions
US20020116730A1 (en) Transgenic mice containing PERK protein kinase gene disruptions
WO2002045495A2 (fr) Souris transgeniques contenant disruptions geniques ciblees
US20020026653A1 (en) Transgenic mice containing serine protease gene disruptions
US6653526B2 (en) Transgenic mice exhibiting increased susceptibility to seizures
US20030014769A1 (en) Transgenic mice containing GPCR-like transmembrane protein disruptions
US20020056146A1 (en) Transgenic mice containing nuclear hormone receptor gene disruptions
US20060156426A1 (en) Transgenic mice containing ABC transporter-like ATPase gene disruptions
US20030014771A1 (en) Transgenic mice containing USP3-like deubiquitinating enzyme gene disruptions
US20060090213A1 (en) Transgenic mice containing Kir5.1 inwardly rectifying potassium channel gene disruptions
US6762342B2 (en) Transgenic mice containing intestinal alkaline phosphatase gene disruptions
US20020129397A1 (en) Transgenic mice containing brain-specific membrane-anchored protein gene disruptions
US20020022719A1 (en) Transgenic mice containing ubiquitin-specific protease gene disruptions
US20060105459A1 (en) Transgenic mice containing NTTP1 phosphatase gene disruptions
US20030093823A1 (en) Transgenic mice containing lumulus clotting factor protease-like gene disruptions
US20060179504A1 (en) Transgenic mice containing deubiquitinated enzyme gene disruptions
US20030005475A1 (en) Transgenic mice containing acylphosphatase gene disruptions
US20020162132A1 (en) Transgenic mice containing DEZ orphan receptor gene disruptions
US20020194636A1 (en) Transgenic mice containing polycystin-related gene disruptions
WO2002046391A2 (fr) Souris transgeniques contenant des interruptions de gene nor1

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US US US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP